Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Melanoma Risk Assessment & Tailored Intervention [NA]
A completed University of Pennsylvania trial evaluating melanoma risk assessment and a tailored intervention. No specific drug is mentioned …
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma [Phase 1]
This update reports the completion of a Phase 1 safety study evaluating the combination of dacarbazine and bortezomib in patients with melan…
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients [Phase 1]
Phase 1 trial update evaluating a multipeptide vaccine combined with toll-like receptor agonists in melanoma patients; the study status is c…
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies [Phase 1]
Phase 1 trial update evaluating a multi-phosphopeptide vaccine in combination with the adjuvant PolyICLC in melanoma patients.
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1 [Phase 2]
Phase 2 trial of ipilimumab in patients with advanced/metastatic melanoma and spontaneous preexisting NY-ESO-1 immune response has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) [Phase 1, Phase 2]
A phase 1/2 study evaluating tumor-infiltrating lymphocytes combined with intra-tumoral injections of Ad-IFNg (interferon gamma-encoding ade…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Dinaciclib in Treating Patients With Stage III-IV Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial of dinaciclib in patients with stage III-IV melanoma has been terminated; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases [Phase 2]
A Phase 2 study of vemurafenib in metastatic melanoma, including patients with brain metastases, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations [Phase 1]
Phase 1 study of vemurafenib in pediatric patients with stage IIIC or stage IV BRAFV600-mutated melanoma was terminated; results were posted…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma [Phase 2]
Phase 2 study of the PARP inhibitor E7016 in combination with temozolomide for wild-type BRAF advanced melanoma (stage IV or unresectable st…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating CAR T cell therapy targeting VEGFR2 in patients with metastatic cancer, terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma [Phase 1, Phase 2]
The Phase I/II clinical trial of GMX1777 in combination with temozolomide for metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells [Phase 2]
Phase 2 trial evaluating an autologous tumor cell and dendritic cell vaccine for metastatic melanoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 2]
Phase 2 trial evaluating aerosolized sargramostim for metastatic melanoma to the lung is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination [NA]
This clinical trial update compares educational interventions designed to teach melanoma patients how to perform skin self-examinations and …
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Everolimus in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating everolimus for stage IV melanoma has been completed. The update summarizes the trial results.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 1]
Phase 1 clinical trial evaluating inhaled sargramostim for melanoma metastatic to the lung has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of immunotherapy using tumor-infiltrating lymphocytes for metastatic melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer [Phase 2]
Phase 2 trial investigating chemotherapy followed by ESO-1 lymphocytes and aldesleukin in metastatic cancer was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: DNA Repair Inhibitor & Irradiation on Melanoma [Phase 1]
Phase 1 trial evaluating a DNA repair inhibitor in combination with irradiation for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of RO4929097, a gamma-secretase/Notch signaling pathway inhibitor, in stage IV melanoma was terminated. Results from the stu…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Interferon Toxicities in Melanoma Treatment
The document reports observed toxicities associated with interferon therapy in the treatment of Stage III melanoma, based on a completed cli…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma [Phase 2]
A Phase 2 trial evaluated ipilimumab after isolated limb perfusion in patients with in-transit metastatic melanoma (Stage IIIB-IIIC); the st…